Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Computing
Conference & Expo
November 2-4, 2009 NYC
Register Today and SAVE !..

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
In many cases, the end of the year gives you time to step back and take stock of the last 12 months. This is when many of us take a hard look at what worked and what did not, complete performance reviews, and formulate plans for the coming year. For me, it is all of those things plus a time when I u...
SYS-CON.TV
Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis

NEW YORK, Dec. 11, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis

http://www.reportlinker.com/p01051324/Pediatric-Vaccines-Market-Doses-Im...

Worldwide pediatric vaccine market has been growing rapidly over the last five years as it has doubled its market share in 2011 compared to 2005. The worldwide pediatrics vaccine market is expected to be more than US$ 23 Billion by 2015 growing with a single digit CAGR during 2012 – 2015. This incremental growth has been due to blockbuster vaccines (Prevnar7, Prevnar 13, Rotarix and Rotateq) sales in Billion of US$ which made a significant contribution.

It is predicted that Pediatric proprietary vaccines will lead the segment with little less than 60% market share by 2015.The combinations & boosters and enhanced pediatric vaccines market are expected to show stagnant growth in future due to lower margins and the mature nature of these markets. Pneumococcal, DTP and Varicella together all these three vaccines control 55% of the market share in 2011.

In number of cases Polio, Haemophiilus Influenzae Type B (HIB) and MMR cases have shown decline continuously from the year 2001 till 2011. Polio remains endemic merely in three countries and the good news is that India has not reported a single case from the past two years and on the verge of being called a polio free country.

DTP are the most utilized vaccines in the pediatric vaccines market which contributed less than 10,000 Million doses in 2011. Pediatric Hepatitis and Polio vaccines are also mostly used vaccines which consumed more than 6,000 Million doses in 2011. In case of Rotavirus vaccine although the price of Rotavirus vaccine has declined but still its present prices are expensive than other pediatric vaccines. However despite all the impediments pediatric vaccines industry is expected to remain highly active in the future, fueled by the encouragement and financing from governments and other health organizations.

Renub Research report titled "Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis" talks about the pediatric vaccines. The report provides information on all the Nine (9) Pediatric Vaccines Market, Doses, Immunization and Number of Cases by region in the world. This report covers in detail all aspects of past, present and future scenario. This report provides market landscape and market share information of the Pediatric Combinations & Booster, Pediatric Enhanced Combination and Pediatric Proprietary Vaccines Market. The report also entails major factors driving the pediatric vaccine market and challenges of pediatric vaccine market.

Pediatric Vaccines Covered in this Report are as follows:

Measles, Mumps & Rubella (MMR) Vaccines, Haemophilus Influenzae Type B (HIB) Vaccines, Polio Vaccines, Diphtheria, Tetanus & Pertussis (Combos) Vaccines, Pneumococcal Vaccines

Rotavirus Vaccines, Hepatitis Pediatric Vaccines, Varicella/Chicken Pox Vaccines and Other Pediatric Vaccines

All the Pediatric Vaccines in this Report have been Studied from Four View Points:

• Number of Cases Reported for all 9 Pediatric Diseases by Region from 2001 to 2011

• Number of Doses Reported and Forecast for all 9 Pediatric Vaccine from 2005 to 2015

• Immunization Coverage for all 9 Pediatric Vaccines and Forecast from 2005 to 2015

• Market Size for all 9 Pediatric Vaccines and Forecast from 2005 to 2015

Key Topics Covered in the Report

• Worldwide – Pediatric Vaccines Market and Forecast (2006 - 2015)

• Worldwide – Pediatric Vaccines Market Share and Forecast (Sector wise) (2005 - 2015)

• Worldwide – Pediatric Vaccines Market Share & Forecast (Disease wise) (2006 - 2015)

• By Sector (All 9) – Pediatric Vaccines Market and Forecast (2005 - 2015)

• By Region - Pediatric Disease Cases (2001 – 2011)

• Pediatric Vaccines Doses and Forecast (2005 – 2015)

• Pediatric Vaccines Immunization Coverage and Forecast (2005 - 2015)

• All 9 Pediatric Vaccines Market and Forecast (2005 - 2015)

• Growth Drivers of Pediatric Vaccines Market

• Challenges of Pediatric Vaccines Market

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases.

Table of Contents

1. Executive Summary

2. Worldwide Pediatric Vaccines Market and Forecast (2006 – 2015)

3. Worldwide – Pediatric Vaccines Market Share & Forecast (Sector wise) (2005 – 2015)

4. Worldwide – Pediatric Vaccines Market Share & Forecast (Disease wise) (2006 – 2015)

5. By Sector – Pediatric Vaccines Market and Forecast (2005 – 2015)

5.1 Worldwide – Pediatric Combinations & Boosters Vaccines Market

5.2 Worldwide – Pediatric Enhanced Combinations Vaccines Market

5.3 Worldwide – Pediatric Proprietary Vaccines Market

6. Major Pediatric Vaccines Cases, Doses, Immunization Coverage, Market and Forecast

6.1 Measles, Mumps & Rubella (MMR) Vaccines and Forecast (2005 – 2015)

6.1.1 Number of Measles, Mumps & Rubella Cases (2001 – 2011)

6.1.2 Number of Measles, Mumps & Rubella (MMR) Vaccines Doses

6.1.3 Immunization Coverage of Measles, Mumps & Rubella (MMR) Vaccines

6.1.4 Market Size of Measles, Mumps & Rubella (MMR) Vaccines

6.2 Haemophilus Influenzae Type B (HIB) Vaccines and Forecast (2005 – 2015)

6.2.1 Number of Haemophilus Influenzae Type B (HIB) Meningitis Cases (2001 – 2011)

6.2.2 Number of Haemophilus Influenzae Type B (HIB) Vaccines Doses

6.2.3 Immunization Coverage of Haemophilus Influenzae Type B (HIB) Vaccines

6.2.4 Market Size of Haemophilus Influenzae Type B (HIB) Vaccines

6.3 Polio Vaccines and Forecast (2005 – 2015)

6.3.1 Number of Polio Cases (2001 – 2011)

6.3.2 Number of Polio Vaccines Doses

6.3.3 Immunization Coverage of Polio Vaccines

6.3.4 Market Size of Polio Vaccines

6.4 Diphtheria, Tetanus & Pertussis (Combos) Vaccines and Forecast (2005 – 2015)

6.4.1 Number of Diphtheria, Tetanus & Pertussis (DTP) Cases (2001 – 2011)

6.4.2 Number of Diphtheria, Tetanus & Pertusis (DTP) Vaccines Doses

6.4.3 Immunization Coverage of Diphtheria, Tetanus & Pertusis (DTP) Vaccines

6.4.4 Market Size of Diphtheria, Tetanus & Pertussis (Combos) Vaccines

6.5 Pneumococcal Vaccines and Forecast (2005 – 2015)

6.5.1 Number of Pneumococcal Cases (2000)

6.5.2 Number of Pneumococcal Vaccines Doses

6.5.3 Immunization Coverage of Pneumococcal Vaccines

6.5.4 Market Size of Pneumococcal Vaccines

6.6 Rotavirus Vaccine and Forecast (2006 – 2015)

6.6.1 Number of Rotavirus Cases (2008 & 2009)

6.6.2 Number of Rotavirus Vaccines Doses

6.6.3 Immunization Coverage of Rotavirus Vaccines

6.6.4 Market Size of Rotavirus Vaccine

6.7 Hepatitis Pediatric Vaccines and Forecast (2005 – 2015)

6.7.1 Number of Hepatitis Pediatric Vaccines Doses

6.7.2 Immunization Coverage of Hepatitis Pediatric Vaccines

6.7.3 Market Size of Hepatitis Pediatric Vaccines

6.8 Varicella/Chicken Pox Vaccines and Forecast (2005 – 2015)

6.8.1 Number of Varicella/Chicken Pox Vaccines Doses

6.8.2 Market Size of Varicella/Chicken Pox Vaccines

6.9 Other Pediatric Vaccines and Forecast (2005 – 2015)

6.9.1 Market Size of Other Pediatric Vaccines

7. Growth Drivers of Pediatric Vaccines Market

7.1 Reduced Price on Rotavirus Vaccines: Enough to Facilitate Growth but More Still Needs To Be Done

7.1.1 Rotavirus Vaccine Introduction

7.1.2 Financial Challenges

7.1.3 Cost Effective

7.1.4 Future Steps

7.1.5 Conclusion

7.2 GAVI Model Increases Vaccine Manufacturers

7.2.1 The Partnership Model

7.2.2 The Business Model

7.3 WHO Global Vaccine Action Plan (2011 - 2020)

8. Challenges of Pediatric Vaccine Market

8.1 Roadblocks in Expanding Access to Newer Pediatric Vaccines

8.2 Impediment in Pediatric Vaccine Research & Development

8.3 Barriers to New Entrants in the Pediatric Vaccines Market

List of Figures

Figure 2 1: Worldwide – Pediatric Vaccines Market (Million US$), 2006 – 2011

Figure 2 2: Worldwide – Forecast for Pediatric Vaccines Market (Million US$), 2012 – 2015

Figure 3 1: Worldwide (Sector wise) – Pediatric Vaccines Market Share (Percent), 2005 – 2011

Figure 3 2: Worldwide (Sector wise) – Forecast for Pediatric Vaccines Market Share (Percent), 2012 – 2015

Figure 5 1: Worldwide – Pediatric Combinations & Boosters Vaccines Market (Million US$), 2005 – 2011

Figure 5 2: Worldwide – Forecast for Pediatric Combinations & Boosters Vaccines Market (Million US$), 2012 – 2015

Figure 5 3: Worldwide – Pediatric Enhanced Combinations Vaccines Market (Million US$), 2005 – 2011

Figure 5 4: Worldwide – Forecast for Pediatric Enhanced Combinations Vaccines Market (Million US$), 2012 – 2015

Figure 5 5: Worldwide – Pediatric Proprietary Vaccines Market (Million US$), 2005 – 2011

Figure 5 6: Worldwide – Forecast for Pediatric Proprietary Vaccines Market (Million US$), 2012 – 2015

Figure 6 1: Worldwide – Number of MMR Vaccines Doses (Million Doses), 2005 – 2011

Figure 6 2: Worldwide – Forecast for Number of MMR Vaccines Doses (Million Doses), 2012 – 2015

Figure 6 3: Worldwide – Immunization Coverage of MMR Vaccines Doses (Million Doses), 2005 – 2011

Figure 6 4: Worldwide – Forecast for Immunization Coverage of MMR Vaccines Doses (Million Doses), 2012 – 2015

Figure 6 5: Worldwide – Measles, Mumps & Rubella Vaccines Market (Million US$), 2005 – 2011

Figure 6 6: Worldwide – Forecast for Measles, Mumps & Rubella Vaccines Market (Million US$), 2012 – 2015

Figure 6 7: Worldwide – Haemophilus Influenzae Type B Vaccine Introduction in High & Low-Income Countries, 1980 – 2010

Figure 6 8: Worldwide – Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses), 2005 – 2011

Figure 6 9: Worldwide – Forecast for Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses), 2012 – 2015

Figure 6 10: Worldwide – Immunization Coverage of Haemophilus Influenzae Type B Vaccines (Million Doses), 2005 – 2011

Figure 6 11: Worldwide – Forecast for Immunization Coverage of Haemophilus Influenzae Type B Vaccines (Million Doses), 2012 – 2015

Figure 6 12: Worldwide – Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2005 – 2011

Figure 6 13: Worldwide – Forecast for Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2012 – 2015

Figure 6 14: Worldwide – Number of Doses of Polio Vaccines (Million Doses), 2005 – 2011

Figure 6 15: Worldwide – Forecast for Number of Doses of Polio Vaccines (Million Doses), 2012 – 2015

Figure 6 16: Worldwide – Immunization Coverage of Polio Vaccines (Million Doses), 2005 – 2011

Figure 6 17: Worldwide – Forecast for Immunization Coverage of Polio Vaccines (Million Doses), 2012 – 2015

Figure 6 18: Worldwide – Polio Vaccines Market (Million US$), 2005 – 2011

Figure 6 19: Worldwide – Forecast for Polio Vaccines Market (Million US$), 2012 – 2015

Figure 6 20: Worldwide – Number of Doses of DTP Vaccines (Million Doses), 2005 – 2011

Figure 6 21: Worldwide – Forecast for Number of Doses of DTP Vaccines (Million Doses), 2012 – 2015

Figure 6 22: Worldwide – Immunization Coverage of DTP Vaccines (Million Doses), 2005 – 2011

Figure 6 23: Worldwide – Forecast for Immunization Coverage of DTP Vaccines (Million Doses), 2012 – 2015

Figure 6 24: Worldwide – Diphtheria, Tetanus & Pertussis (Combos) Vaccines Market (Million US$), 2005 – 2011

Figure 6 25: Worldwide – Forecast for Diphtheria, Tetanus & Pertussis (Combos) Vaccines Market (Million US$), 2012 – 2015

Figure 6 26: Worldwide – Pneumococcal Vaccine Pipeline, 2000 – 2025

Figure 6 27: Worldwide – Number of Doses of Pneumococcal Vaccines (Million Doses), 2010 – 2011

Figure 6 28: Worldwide – Forecast for Number of Doses of Pneumococcal Vaccines (Million Doses), 2012 – 2015

Figure 6 29: Worldwide – Immunization Coverage of Pneumococcal Vaccines (Million Doses), 2010 – 2011

Figure 6 30: Worldwide – Forecast for Immunization Coverage of Pneumococcal Vaccines (Million Doses), 2012 – 2015

Figure 6 31: Worldwide – Pneumococcal Vaccines Market (Million US$), 2005 – 2011

Figure 6 32: Worldwide – Forecast for Pneumococcal Vaccines Market (Million US$), 2012 – 2015

Figure 6 33: Worldwide – Number of Doses of Rotavirus Vaccines (Million Doses), 2010 – 2011

Figure 6 34: Worldwide – Forecast for Number of Doses of Rotavirus Vaccines (Million Doses), 2012 – 2015

Figure 6 35: Worldwide – Immunization Coverage of Rotavirus Vaccines (Million Doses), 2010 – 2011

Figure 6 36: Worldwide – Forecast for Immunization Coverage of Rotavirus Vaccines (Million Doses), 2012 – 2015

Figure 6 37: Worldwide – Rotavirus Vaccine Market (Million US$), 2006 – 2011

Figure 6 38: Worldwide – Forecast for Rotavirus Vaccine Market (Million US$), 2012 – 2015

Figure 6 39: Worldwide – Number of Doses of Hepatitis Pediatric Vaccines (Million Doses), 2005 – 2011

Figure 6 40: Worldwide – Forecast for Number of Doses of Hepatitis Pediatric Vaccines (Million Doses), 2012 – 2015

Figure 6 41: Worldwide – Immunization Coverage of Hepatitis Pediatric Vaccines (Million Doses), 2005 – 2011

Figure 6 42: Worldwide – Forecast for Immunization Coverage of Hepatitis Pediatric Vaccines (Million Doses), 2012 – 2015

Figure 6 43: Worldwide – Hepatitis B Vaccine Introduction in High & Low-income countries, 1980 – 2010

Figure 6 44: Worldwide – Hepatitis Pediatric Vaccines Market (Million US$), 2005 – 2011

Figure 6 45: Worldwide – Forecast for Hepatitis Pediatric Vaccines Market (Million US$), 2012 – 2015

Figure 6 46: Worldwide – Number of Doses of Varicella Vaccines (Million Doses), 2005 – 2011

Figure 6 47: Worldwide – Forecast for Number of Doses of Varicella Vaccines (Million Doses), 2012 – 2015

Figure 6 48: Worldwide – Varicella Vaccines Market (Million US$), 2005 – 2011

Figure 6 49: Worldwide – Forecast for Varicella Vaccines Market (Million US$), 2012 – 2015

Figure 6 50: Worldwide – Other Pediatric Vaccines Market (Million US$), 2005 – 2011

Figure 6 51: Worldwide – Forecast for Other Pediatric Vaccines Market (Million US$),2012 – 2015

Figure 7 1: Prices of Childhood Vaccines (US$), 2011

Figure 7 2: Reduction in Rotavirus Vaccine Prices (US$), May 2011 & April 2012

Figure 7 3: Increasing Number of GAVI Suppliers Based in Emerging Markets

List of Tables

Table 4 1: Worldwide (Disease wise) – Pediatric Vaccines Market Share (Percent), 2006 – 2011

Table 4 2: Worldwide (Disease wise) – Forecast for Pediatric Vaccines Market Share (Percent), 2012 – 2015

Table 6 1: Worldwide (By Geographic Region) – Number of Measles Cases (Number), 2001 – 2011

Table 6 2: Worldwide (By Geographic Region) – Number of Mumps Cases (Number), 2001 – 2011

Table 6 3: Worldwide (By Geographic Region) – Number of Rubella Cases (Number), 2001 – 2011

Table 6 4: Worldwide (By Geographic Region) – Number of Haemophilus Influenzae Type B Meningitis Cases (Number), 2001 – 2011

Table 6 5: Worldwide (By Geographic Region) – Number of Polio Cases (Number), 2001 – 2011

Table 6 6: Worldwide (By Geographic Region) – Number of Diphtheria Cases (Number), 2001 – 2011

Table 6 7: Worldwide (By Geographic Region) – Number of nTetanus Cases (Number), 2001 – 2011

Table 6 8: Worldwide (By Geographic Region) – Number of tTetanus Cases (Number), 2001 – 2011

Table 6 9: Worldwide (By Geographic Region) – Number of Pertusis Cases (Number), 2001 – 2011

Table 6 10: Worldwide (By Geographic Region) – Pneumococcal Cases & Death in Children Under 5 Years of Age (Number), 2000

Table 6 11: Worldwide (By Geographic Region) – WHO Coordinated Rotavirus Surveillance (Number), 2008 – 2009

Table 6 12: Worldwide (By Geographic Region) – WHO Coordinated Rotavirus Surveillance Positive Cases (Number & Percent), 2009

Table 7 1: Worldwide – Total Future Deaths Averted through Vaccination (Million), 2011 – 2020

Table 7 2: Goal-Level Indicators, 2015 & 2020

To order this report:

Drug_and_Medication Industry: Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis

Contact Nicolas: nicolasbombourg@reportlinker.com
US: (805)-652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

SOA World Latest Stories
The definition of IoT is not new, in fact it’s been around for over a decade. What has changed is the public's awareness that the technology we use on a daily basis has caught up on the vision of an always on, always connected world. If you look into the details of what comprises the I...
The 4th International DevOps Summit, co-located with16th International Cloud Expo – being held June 9-11, 2015, at the Javits Center in New York City, NY – announces that its Call for Papers is now open. Born out of proven success in agile development, cloud computing, and process aut...
Verizon Enterprise Solutions is simplifying the cloud-purchasing experience for its clients, with the launch of Verizon Cloud Marketplace, a key foundational component of the company's robust ecosystem of enterprise-class technologies. The online storefront will initially feature pre-b...
To manage complex web services with lots of calls to the cloud, many businesses have invested in Application Performance Management (APM) and Network Performance Management (NPM) tools. Together APM and NPM tools are essential aids in improving a business's infrastructure required to s...
In her General Session at 15th Cloud Expo, Anne Plese, Senior Consultant, Cloud Product Marketing, at Verizon Enterprise, focused on finding the right mix of renting vs. buying Oracle capacity to scale to meet business demands, and offer validated Oracle database TCO models for Oracle ...
What’s Big Data without Big Compute? Basically just a large collection of unstructured information with little purpose and value. It’s not enough for data just to exist, we must derive value from it through computation – something commonly referred to as analytics. With traditional ...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021


SYS-CON Featured Whitepapers
ADS BY GOOGLE